These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12447943)

  • 1. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study.
    Khan NL; Valente EM; Bentivoglio AR; Wood NW; Albanese A; Brooks DJ; Piccini P
    Ann Neurol; 2002 Dec; 52(6):849-53. PubMed ID: 12447943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
    Hilker R; Klein C; Ghaemi M; Kis B; Strotmann T; Ozelius LJ; Lenz O; Vieregge P; Herholz K; Heiss WD; Pramstaller PP
    Ann Neurol; 2001 Mar; 49(3):367-76. PubMed ID: 11261512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
    Piccini P; de Yebenez J; Lees AJ; Ceravolo R; Turjanski N; Pramstaller P; Brooks DJ
    Arch Neurol; 2001 Nov; 58(11):1846-51. PubMed ID: 11708994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.
    Pavese N; Khan NL; Scherfler C; Cohen L; Brooks DJ; Wood NW; Bhatia KP; Quinn NP; Lees AJ; Piccini P
    Mov Disord; 2009 Nov; 24(15):2260-6. PubMed ID: 19845000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
    Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
    Nurmi E; Bergman J; Eskola O; Solin O; Vahlberg T; Sonninen P; Rinne JO
    Synapse; 2003 Jun; 48(3):109-15. PubMed ID: 12645035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
    Pal PK; Leung J; Hedrich K; Samii A; Lieberman A; Nausieda PA; Calne DB; Breakefield XO; Klein C; Stoessl AJ
    Mov Disord; 2002 Jul; 17(4):789-94. PubMed ID: 12210877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study.
    Khan NL; Brooks DJ; Pavese N; Sweeney MG; Wood NW; Lees AJ; Piccini P
    Brain; 2002 Oct; 125(Pt 10):2248-56. PubMed ID: 12244082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred.
    Sawle GV; Wroe SJ; Lees AJ; Brooks DJ; Frackowiak RS
    Ann Neurol; 1992 Nov; 32(5):609-17. PubMed ID: 1449241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.
    Burn DJ; Brooks DJ
    Neurology; 1993 Mar; 43(3 Pt 1):552-6. PubMed ID: 8451000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case of a 30-year history of PARK6 --findings from functional imaging of the brain].
    Yamashita H; Kohriyama T; Ohshita T; Takahashi T; Hashikawa K; Hattori N; Fukuyama H; Matsumoto M
    Rinsho Shinkeigaku; 2008 Sep; 48(9):662-5. PubMed ID: 19048950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.
    Ribeiro MJ; Thobois S; Lohmann E; du Montcel ST; Lesage S; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Broussolle E; Brice A; Remy P;
    J Nucl Med; 2009 Aug; 50(8):1244-50. PubMed ID: 19617340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
    Adams JR; van Netten H; Schulzer M; Mak E; Mckenzie J; Strongosky A; Sossi V; Ruth TJ; Lee CS; Farrer M; Gasser T; Uitti RJ; Calne DB; Wszolek ZK; Stoessl AJ
    Brain; 2005 Dec; 128(Pt 12):2777-85. PubMed ID: 16081470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PINK1-linked parkinsonism is associated with Lewy body pathology.
    Samaranch L; Lorenzo-Betancor O; Arbelo JM; Ferrer I; Lorenzo E; Irigoyen J; Pastor MA; Marrero C; Isla C; Herrera-Henriquez J; Pastor P
    Brain; 2010 Apr; 133(Pt 4):1128-42. PubMed ID: 20356854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic function in patients with posttraumatic parkinsonism: an 18F-dopa PET study.
    Turjanski N; Lees AJ; Brooks DJ
    Neurology; 1997 Jul; 49(1):183-9. PubMed ID: 9222188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARK6 is a common cause of familial parkinsonism.
    Valente EM; Brancati F; Caputo V; Graham EA; Davis MB; Ferraris A; Breteler MM; Gasser T; Bonifati V; Bentivoglio AR; De Michele G; Dürr A; Cortelli P; Filla A; Meco G; Oostra BA; Brice A; Albanese A; Dallapiccola B; Wood NW;
    Neurol Sci; 2002 Sep; 23 Suppl 2():S117-8. PubMed ID: 12548371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of preclinical Parkinson's disease with PET.
    Brooks DJ
    Geriatrics; 1991 Aug; 46 Suppl 1():25-30. PubMed ID: 1909983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease.
    Menza MA; Mark MH; Burn DJ; Brooks DJ
    J Neuropsychiatry Clin Neurosci; 1995; 7(2):176-9. PubMed ID: 7626960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
    Whone AL; Watts RL; Stoessl AJ; Davis M; Reske S; Nahmias C; Lang AE; Rascol O; Ribeiro MJ; Remy P; Poewe WH; Hauser RA; Brooks DJ;
    Ann Neurol; 2003 Jul; 54(1):93-101. PubMed ID: 12838524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study.
    Piccini P; Morrish PK; Turjanski N; Sawle GV; Burn DJ; Weeks RA; Mark MH; Maraganore DM; Lees AJ; Brooks DJ
    Ann Neurol; 1997 Feb; 41(2):222-9. PubMed ID: 9029071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.